progression-free survival

Explore academic connections and research related to this keyword

178
Views
8
Total Connections
Search More Keywords

Related Articles & Bibliographies

1
Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study.
Dane, Faysal;Ozgurdal, Kirhan;Yalçın, Şuayib;Benekli, Mustafa;Aykan, Nuri Faruk;Yücel, İdris;Özkan,...
2020 BMJ open DOI: 10.1136/bmjopen-2018... 202 views
2
pre/post-treatment dynamic of inflammatory markers has prognostic value in patients with small hepatocellular carcinoma managed by stereotactic body radiation therapy
;Zhuang Y;Yuan BY;Hu Y;Chen GW;Zhang L;Zhao XM;Chen YX;Zeng ZC
2020 teknik 230 views
3
Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study.
Benekli, Mustafa;Gumus, Mahmut;Ozkan, Metin;Dane, Faysal;Elkiran, Emin T;Cicin, Irfan;Sevinc, Alper;...
2020 Journal of oncology pharmacy practice : official p... DOI: 10.1177/107815522096... 238 views
4
A systematic review of medicinal plants used against Echinococcus granulosus.
Ali, Rehman;Khan, Sanaullah;Khan, Marina;Adnan, Muhammad;Ali, Ijaz;Khan, Taj Ali;Haleem, Sumbal;Room...
2020 PloS one DOI: 10.1371/journal.pone... 211 views

Related Journals

PloS one
ISSN: 1932-6203 952 views
BMJ open
ISSN: 2044-6055 1,062 views
Haematologica
ISSN: 1592-8721 401 views
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
ISSN: 1477-092X 519 views

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

Turkey clinical trial multikinase inhibitor toxicities hepatocellular carcinoma neutrophil-to-lymphocyte ratio platelet-to-lymphocyte ratio Oncology including cancer and carcinogens tumors safety tyrosine kinase inhibitors overall survival metastatic renal cell carcinoma cytokine intolerance